Musculo-scrawny Manifestation Associated With the Endometriosis

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Completed
CT.gov ID
NCT03305120
Collaborator
(none)
41
1
3.5
11.8

Study Details

Study Description

Brief Summary

The endometriosis is defined by the presence of endometriosic tissue outside of the womb and the prevalence is estimated to be 10% of women.Here is a project aimed to compare musculo-scrawny pains between patients with endometriosis and whose don't suffer of this pathology;

Condition or Disease Intervention/Treatment Phase
  • Other: pain VAS evaluation

Study Design

Study Type:
Observational
Actual Enrollment :
41 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Musculo-scrawny Manifestation Associated With the Endometriosis
Actual Study Start Date :
Sep 16, 2016
Actual Primary Completion Date :
Oct 16, 2016
Actual Study Completion Date :
Dec 31, 2016

Outcome Measures

Primary Outcome Measures

  1. VAS of musculo-scrawny pain [Day 1]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age between 18 and 45

  • consulting in Service of gynecology

  • First trimester of pregnancy or for pap smears

Exclusion Criteria:
  • endometriosis diagnostic already done

  • rhumalogic disease known

  • age < 18 and > 50

  • menopause

Contacts and Locations

Locations

Site City State Country Postal Code
1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

Sponsors and Collaborators

  • Groupe Hospitalier Paris Saint Joseph

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Groupe Hospitalier Paris Saint Joseph
ClinicalTrials.gov Identifier:
NCT03305120
Other Study ID Numbers:
  • ENDOMETRI-OS
First Posted:
Oct 9, 2017
Last Update Posted:
Oct 9, 2017
Last Verified:
Oct 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2017